149 related articles for article (PubMed ID: 32763386)
1. Hyaluronic acid-drug conjugate modified core-shell MOFs as pH responsive nanoplatform for multimodal therapy of glioblastoma.
Pandey A; Kulkarni S; Vincent AP; Nannuri SH; George SD; Mutalik S
Int J Pharm; 2020 Oct; 588():119735. PubMed ID: 32763386
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid tethered pH-responsive alloy-drug nanoconjugates for multimodal therapy of glioblastoma: An intranasal route approach.
Pandey A; Singh K; Patel S; Singh R; Patel K; Sawant K
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():419-436. PubMed ID: 30813043
[TBL] [Abstract][Full Text] [Related]
3. ZIF-8 nano confined protein-titanocene complex core-shell MOFs for efficient therapy of Neuroblastoma: Optimization, molecular dynamics and toxicity studies.
Kulkarni S; Pandey A; Nikam AN; Nannuri SH; George SD; Fayaz SMA; Vincent AP; Mutalik S
Int J Biol Macromol; 2021 May; 178():444-463. PubMed ID: 33636277
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable Imprinted Polymer Based on ZIF-8/DOX-HA for Synergistically Targeting Prostate Cancer Cells and Controlled Drug Release with Multiple Responses.
Song Y; Han S; Liu S; Sun R; Zhao L; Yan C
ACS Appl Mater Interfaces; 2023 May; 15(21):25339-25353. PubMed ID: 37212295
[TBL] [Abstract][Full Text] [Related]
5. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin.
Liao J; Zheng H; Fei Z; Lu B; Zheng H; Li D; Xiong X; Yi Y
Int J Biol Macromol; 2018 Jul; 113():737-747. PubMed ID: 29505869
[TBL] [Abstract][Full Text] [Related]
7. A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment.
Yin Y; Fu C; Li M; Li X; Wang M; He L; Zhang LM; Peng Y
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():159-169. PubMed ID: 27287110
[TBL] [Abstract][Full Text] [Related]
8. One-pot synthesis of folic acid encapsulated upconversion nanoscale metal organic frameworks for targeting, imaging and pH responsive drug release.
Chowdhuri AR; Laha D; Pal S; Karmakar P; Sahu SK
Dalton Trans; 2016 Nov; 45(45):18120-18132. PubMed ID: 27785489
[TBL] [Abstract][Full Text] [Related]
9. ZnO-DOX@ZIF-8 Core-Shell Nanoparticles for pH-Responsive Drug Delivery.
Zheng C; Wang Y; Phua SZF; Lim WQ; Zhao Y
ACS Biomater Sci Eng; 2017 Oct; 3(10):2223-2229. PubMed ID: 33445281
[TBL] [Abstract][Full Text] [Related]
10. pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy.
Obaid EAMS; Wu S; Zhong Y; Yan M; Zhu L; Li B; Wang Y; Wu W; Wang G
Biomater Sci; 2022 Aug; 10(17):4837-4847. PubMed ID: 35858474
[TBL] [Abstract][Full Text] [Related]
11. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy.
Sun Q; Bi H; Wang Z; Li C; Wang X; Xu J; Zhu H; Zhao R; He F; Gai S; Yang P
Biomaterials; 2019 Dec; 223():119473. PubMed ID: 31499255
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA.
Wang T; Yu X; Han L; Liu T; Liu Y; Zhang N
Int J Nanomedicine; 2017; 12():4773-4788. PubMed ID: 28740384
[TBL] [Abstract][Full Text] [Related]
14. Enzyme and pH dual-responsive hyaluronic acid nanoparticles mediated combination of photodynamic therapy and chemotherapy.
Ren Q; Liang Z; Jiang X; Gong P; Zhou L; Sun Z; Xiang J; Xu Z; Peng X; Li S; Li W; Cai L; Tang J
Int J Biol Macromol; 2019 Jun; 130():845-852. PubMed ID: 30844454
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic Acid-Functionalized Gold Nanorods with pH/NIR Dual-Responsive Drug Release for Synergetic Targeted Photothermal Chemotherapy of Breast Cancer.
Xu W; Qian J; Hou G; Suo A; Wang Y; Wang J; Sun T; Yang M; Wan X; Yao Y
ACS Appl Mater Interfaces; 2017 Oct; 9(42):36533-36547. PubMed ID: 28975790
[TBL] [Abstract][Full Text] [Related]
16. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
17. pH-Responsive Polymer-Stabilized ZIF-8 Nanocomposites for Fluorescence and Magnetic Resonance Dual-Modal Imaging-Guided Chemo-/Photodynamic Combinational Cancer Therapy.
Qin YT; Peng H; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2019 Sep; 11(37):34268-34281. PubMed ID: 31454217
[TBL] [Abstract][Full Text] [Related]
18. Chromium-Doped Zinc Gallogermanate@Zeolitic Imidazolate Framework-8: A Multifunctional Nanoplatform for Rechargeable In Vivo Persistent Luminescence Imaging and pH-Responsive Drug Release.
Lv Y; Ding D; Zhuang Y; Feng Y; Shi J; Zhang H; Zhou TL; Chen H; Xie RJ
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1907-1916. PubMed ID: 30566326
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging-Guided Multi-Drug Chemotherapy and Photothermal Synergistic Therapy with pH and NIR-Stimulation Release.
Yang JC; Chen Y; Li YH; Yin XB
ACS Appl Mater Interfaces; 2017 Jul; 9(27):22278-22288. PubMed ID: 28616966
[TBL] [Abstract][Full Text] [Related]
20. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
